Soft Bifocal Contact Lenses for Near-sightedness
(BLINK2 Trial)
What You Need to Know Before You Apply
What is the purpose of this trial?
This project intends to provide important, previously unmet answers regarding biological associations with myopia (nearsightedness) progression in order to improve the ability to predict patients who are most likely to benefit from myopia control, as well as questions frequently posed by patients and practitioners about the side effects, mechanism, and discontinuation of soft bifocal contact lens myopia control. The first three aims examine the association between biological variables that can be measured non-invasively and myopia progression, and they will be conducted regardless of the outcome of the currently in progress BLINK Study. The last three specific aims will be conducted if soft bifocal contact lenses slowed myopia progression by 30% or more in the BLINK Study, and they can be investigated with very few additional measurements.
Who Is on the Research Team?
Jeffrey J Walline, OD PhD
Principal Investigator
The Ohio State University College of Optometry
Are You a Good Fit for This Trial?
This trial is for individuals who were part of the BLINK Study, focusing on those with near-sightedness (myopia). It aims to identify biological factors that could predict which patients will benefit most from myopia control using soft bifocal contact lenses.Inclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants wear soft bifocal contact lenses to assess their effect on myopia progression
Transition
Participants switch from bifocal to single vision contact lenses to assess rebound effects
Follow-up
Participants are monitored for safety and effectiveness after treatment
What Are the Treatments Tested in This Trial?
Interventions
- Soft Bifocal Contact Lens
Find a Clinic Near You
Who Is Running the Clinical Trial?
Ohio State University
Lead Sponsor
University of Houston
Collaborator